GlassScriptPhysician profile
Samer Saiedy
NPI 1326159864
$7,201.02
in general payments reported to CMS, 2019-2025
17 companies · $2,599 in 2025
The $2,599 reported for 2025 was more than what 95% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $451 · 2020: $790 · 2021: $363 · 2022: $330 · 2023: $1,108 · 2024: $1,561 · 2025: $2,599.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,268.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,267.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $1,986.52 | 2019-2025 | Igt Devices Systems Undivided, (5028) Igt Devices Systems Undivided, (Bs1) Peripheral Vascular Undivided |
| Bard Peripheral Vascular, INC. | $1,494.62 | 2023-2025 | Rotarexs 6 F X 135 Cm, Lifestent Solo Vascular Stent, Fluency Endovascular Stent Graft |
| Medtronic, INC. | $1,486.64 | 2021-2025 | Turbohawk, Abre, Hawkone |
| Boston Scientific Corporation | $391.25 | 2019-2025 | Angiojet Ultra 5000a |
| Terumo Medical Corporation | $309.30 | 2020-2024 | Glidewire |
| Janssen Pharmaceuticals, INC | $245.76 | 2020-2023 | Xarelto |
| Medtronic Vascular, INC. | $232.74 | 2019-2020 | |
| Canon Medical Systems USA, INC. | $228.83 | 2020-2023 | Interventional Angiography System |
| Aroa Biosurgery Incorporated | $197.31 | 2023 | |
| Mindray Ds USA, INC. | $152.65 | 2025 | Te X, Te7 Max |
| Penumbra, INC. | $135.30 | 2020 | |
| Abbott Laboratories | $129.77 | 2024 | Diamondback Peripheral |
| Silk Road Medical, INC. | $106.67 | 2021 | |
| Becton, Dickinson and Company | $46.48 | 2024 | Rotarexs 6 F X 135 Cm |
| Abbvie INC. | $30.90 | 2023 | Teflaro |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $13.66 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $12.62 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samer Saiedy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.